Announcements Trials
Browse Landscape

Phase

Phase NA 26Phase 3 10Phase 4 4Phase 1 4Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 134Neoplasms 112Polycystic Ovary Syndrome 66Prostatic Neoplasms 63Colorectal Neoplasms 51Carcinoma, Non-Small-Cell Lung 46Pain 40Carcinoma, Hepatocellular 35Lung Neoplasms 34Keratosis, Actinic 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Neoplasm Metastasis 26Head and Neck Neoplasms 26Pain, Postoperative 25Stomach Neoplasms 24Colonic Neoplasms 23Multiple Myeloma 22Brain Neoplasms 21Pancreatic Neoplasms 20Lymphoma, Follicular 19Leukemia 19Anemia 19Uterine Cervical Neoplasms 18Leukemia, Myeloid, Acute 18Infertility 18Leiomyoma 17Lymphoma, Non-Hodgkin 16Lymphoma 16Cancer Pain 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15

Interventions

Lidocaine 2carbetocin 1Uterine Artery Embolization 1Sodium Chloride 1Saline Solution 1Anesthetics, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Completed × Myofibroma × Clear all
NCT04482959 2022-04-06

Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy

Mansoura University Hospital

Phase 4 Completed
40 enrolled

Myofibroma

NCT00995878 2018-01-12

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

Mayo Clinic

Phase 4 Completed
56 enrolled

Leiomyoma, Myoma, Pelvic Pain, Myofibroma

NCT02293447 2016-05-12

Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization

University Health Network, Toronto

Phase 4 Completed
60 enrolled

Leiomyoma, Pain, Myofibroma

NCT01492179 2014-05-28

PoPuLAR

Örebro University, Sweden

Phase 4 Completed
60 enrolled
Gynecologic

Pain, Postoperative, Uterine Neoplasms, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡